Thymosin β4 inhibits TNF-α-induced NF-κB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK

FASEB Journal

Volumn 25, Issue 6, 2011, Pages 1815-1826

  Qiu, Ping ^a   Wheater, Michelle Kurpakus ^b   Qiu, Yue ^a,d   Sosne, Gabriel ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF DETROIT MERCY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DARTMOUTH COLLEGE   (United States)

Author keywords

Actin; Chemokine; Cornea; Cytokine; Focal adhesion; Inflammation

Indexed keywords

G ACTIN; INTEGRIN LINKED KINASE; INTERLEUKIN 8; PINCH 1 PROTEIN; PROTEIN; THYMOSIN BETA4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACTIN; ANTIINFLAMMATORY AGENT; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN-LINKED KINASE; LIMS1 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; THYMOSIN; THYMOSIN BETA(4);

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORNEA CELL; CORNEA EPITHELIUM; DRUG MECHANISM; EPITHELIUM CELL; FIBROBLAST; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN LOCALIZATION; RAT; ANIMAL; CELL CULTURE; CELL STRAIN COS1; CERCOPITHECUS; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY;

ACTINS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; MUTATION; NF-KAPPA B; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RATS; THYMOSIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957922304     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-167940     Document Type: Article

References (79)

1. Low, T. L., and Goldstein, A. L. (1982) Chemical characterization of thymosin beta 4. J. Biol. Chem. 257, 1000-1006
2. Hannappel, E., and van Kampen, M. (1987) Determination of thymosin beta 4 in human blood cells and serum. J. Chromatogr. 397, 279-285 (Pubitemid 17109698)
3. Goldstein, A. L., Hannappel, E., and Kleinman, H. K. (2005) Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 11, 421-429
4. 4. Trends Cardiovasc. Med. 18, 205-210
5. Huang, C. M., Wang, C. C., Barnes, S., and Elmets, C. A. (2006) In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteomics. Proteomics 6, 5805-5814
6. Bodendorf, S., Born, G., and Hannappel, E. (2007) Determination of thymosin b4 and protein in human wound fluid after abdominal surgery. Ann. N. Y. Acad. Sci. 1112, 418-424 (Pubitemid 47598662)
7. Inzitari, Cabras, T., E., Pisano, C., Fanali, B., Manconi, E., Scarano, A., Fiorita, G., Paludetti, S., Nemolato, G., Faa, M., Castagnola, M., and Messana, I. (2009) HPLC-ESI-MS analysis of oral human fluids reveals that gingival crevicular fluids is the main source of oral thymosin β4 and β10. J. Sep. Sci. 32, 57-63
8. Gnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhang, L., Morello, F., Mu, H., Melo, L. G., Pratt, R. E., Ingwall, J., S., and Dzau, V. J. (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20, 661-669 (Pubitemid 44933310)
9. Hinkel, R., El-Aouni, C., Olson, T., Horstkotte, J., Mayer, S., Müller, S., Willhauck, M., Spitzweg, C., Gildehaus, F. J., Münzing, W., Hannappel, E., Bock-Marquette, I., DiMaio, J. M., Hatzopoulos, A. K., Boekstegers, P., and Kupatt, C. (2008) Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation 117, 2232-2240
10. Bock-Marquette, I., Saxena, A., White, M. D., Dimaio, J. M., and Srivastava, D. (2004) Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432, 466-472 (Pubitemid 39576522)
11. Brieger, A., Plotz, G., Zeuzem, S., and Trojan. J. (2007) Thymosin beta 4 expression and nuclear transport are regulated by hMLH1. Biochem. Biophys. Res. Commun. 364, 731-736 (Pubitemid 350103693)
12. Bednarek, R., Boncela, J., Smolarczyk, K., Cierniewska-Cieslak, A., Wyroba, E., and Cierniewski. C. S. (2008) Ku80 as novel receptor for thymosin β4 that mediates its intracellular activity different from G-actin sequestering. J. Biol. Chem. 283, 1534-1544
13. Lee, S. J., So, I. S., Park, S. Y., and Kim, I. S. (2008) Thymosin β4 is involved in stabilin-2-mediated apoptotic cell engulfment. FEBS Lett. 582, 2161-2166
14. Sosne, G., Chan, C. C., Thai, K., Kennedy, M., Szliter, E. A., Hazlett, L. D., and Kleinman, H. K. (2001) Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp. Eye Res. 72, 605-608
15. Sosne, G., Szliter, E. A., Barrett, R., Kernacki, K. A., Kleinman, H., and Hazlett, L. D. (2002) Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp. Eye Res. 74, 293-299
16. Sosne, G., Siddiqi, A., and Kurpakus-Wheater, M. (2004) Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. Invest. Ophthalmol. Vis. Sci. 45, 1095-1100 (Pubitemid 38869013)
17. Sosne, G., Albeiruti, A. R., Hollis, B., Siddiqi, A., Ellenberg, D., and Kurpakus-Wheater, M. (2006) Thymosin beta4 inhibits benzalkonium chloride-mediated apoptosis in corneal and conjunctival epithelial cells in vitro. Exp. Eye Res. 83, 502-507 (Pubitemid 44183802)
18. Bock-Marquette, I., Shrivastava, S., Pipes, G. C., Thatcher, J. E., Blystone, A., Shelton, J. M., Galindo, C. L., Melegh, B., Srivastava, D., Olson, E. N., and DiMaio. J. H. (2009) Thymosin β4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo. J. Mol. Cell. Cardiology 46, 728-738
19. Choi, S. Y., Noh, M. R., Kim, D. K., Sun, W., and Kim, H. (2007) Neuroprotective function of thymosin-beta and its derivative peptides on the programmed cell death of chick and rat neurons. Biochem. Biophys. Res. Commun. 362, 587-593 (Pubitemid 47376681)
20. Qiu, P., Kurpakus-Wheater, M., and Sosne, G. (2007) Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migration. J. Cell. Physiol. 212, 165-173 (Pubitemid 46867598)
21. 4 on neuronal survival and neurite outgrowth by upregulating L1 expression. Neurochem. Res. 33, 2269-2280
22. Reti, R., Kwon, E., Qiu, P., Wheater, M., and Sosne, G. (2008) Thymosin beta4 is cytoprotective in human gingival fibroblasts. Eur. J. Oral. Sci. 116, 424-430
23. 4 prevents apoptosis in human intervertebral annulus cells in vitro. Biotech. Histochem. 84, 287-294
24. 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat. Med. 5, 1424-1427
25. Sosne, G., Christopherson, P. L., Barrett, R. P., and Fridman, R. (2005) Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest. Ophthalmol. Vis. Sci. 46, 2388-2395 (Pubitemid 43119484)
26. Tang, Y. Q., Yeaman, M., and Selsted, M. E. (2002) Antimicrobial peptides from human platelets. Infect. Immun. 70, 6524-6533
27. 4 reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int. Immunopharmacol. 3, 1225-1233
28. Schillaci, D., Arizza, V., Parrinello, N., Di Stefano, V., Fanara, S., Muccilli, V., Cunsolo, V., Haagensen, J. J., and Molin, S. (2009) Antimicrobial and antistaphyllococcal biofilm activity from the sea urchin Paracentrotus lividus. J. App. Microbiol. 108, 17-24
29. 4 and its n-terminal tetrapeptide, AcSDKP, inhibit proliferation, and induce dysplastic, nonapoptic nuclei and degranulation of mast cells. Chem. Biodiver. 1, 1091-1100
30. Sosne, G., Qiu, P., Christopherson, P. L., and Wheater, M. K. (2007) Thymosin beta 4 suppression of corneal NF-κB: a potential anti-inflammatory pathway. Exp. Eye Res. 84, 663-669
31. Lee. H.R., Yoon, S. Y., Kang, H. B., Park, S., Kim, K. E., Cho, Y. H., Kim, S., Kim, C. W., Cho, B. J., Lee, W. J., Bang, S. I., Park, H., and Cho, D. (2009) Thymosin beta 4 enhances NK cell cytotoxicity mediated by ICAM-1. Immun. Lett. 123, 72-76
32. Aggarwal, B. B. (2003) Signaling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 9, 745-756
33. Bradley, J. (2008) TNF-mediated inflammatory disease. J. Path. 214, 149-160
34. Sharma, S. M., Nestel, A. R., Lee, R. W., and Dick, A. D. (2009) Clinical review: Anti-TNFα therapies in uveitis: perspective on 5 years of clinical experience. Ocul. Immunol. Inflamm. 17, 403-414
35. Ghosh, S., and Hayden, M. S. (2008) New regulators of NF-κB in inflammation. Nat. Rev. Immunol. 8, 837-848
36. Pasparakis, M. (2009) Regulation of tissue homeostasis by NF-κB signaling: implications for inflammatory diseases. Nat. Rev. Immunol. 9, 778-788
37. Vallabhapurapu, S., and Karin, M. (2009) Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733
38. Perkins, N. D. (2007) Integrating cell-signaling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62
39. Renner, F., and Schmitz, M. L. (2009) Autoregulatory feedback loops terminating the NF-κB response. Trends Biochem. Sci. 34, 128-135
40. Baeuerle, P. A. (1998) IκB-NF-κB structures: At the interface of inflammation control. Cell 95, 729-731
41. Truhlar, S. M. E., Torpey, J. W., and Komives, E. A. (2006) Regions of IκBα that are critical for its inhibition of NF-κB·DNA interaction fold upon binding to NF-κB. Proc. Natl. Acad. Sci. U. S. A. 103, 18951-18956
42. Tanaka, T., Grusby, M. J., and Kaisho, T. (2007) PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of p65 subunit. Nat. Immunol. 8, 584-591 (Pubitemid 46785122)
43. Trubiani, O., De Fazio, P., Pieri, C., Mazzanti, L., and Di Primio, R. (2000) Nuclear matrix provides linkage sites for translocated NF-κB: morphological evidence. Histochem. Cell Biol. 113, 369-377 (Pubitemid 30341304)
44. Babakov, V. N., Petukhova, O. A., Turoverova, L. V., Kropacheva, I. V., Tentler, D. G., Bolshakova, A. V., Podolskaya, E. P., Magnusson, K. E., and Pinaev, G. P. (2008) RelA/NF-κB transcription factor associates with α-actinin-4. Exp. Cell Res. 314, 1030-1038
45. Kustermans, G., El Mjiyad, N., Horion, J., Jacobs, N., Piette, J., and Legrand-Poels, S. (2008) Actin cytoskeleton differentially modulates NF-κB-mediated IL-8 expression in myelomonocytic cells. Biochem. Pharmacol. 76, 1214-1228
46. Nemeth, Z. H., Deitch, E. A., Davidson, M. T., Szabo, C., Vizi, E. S., and Hasko, G. (2004) Disruption of the actin cytoskeleton results in nuclear factor-κB activation and inflammatory mediator production in cultureed human intestinal epithelial cells. J. Cell. Physiol. 200, 71-81 (Pubitemid 38720623)
47. Fazal, F., Minhajuddin, M., Bijli, K. M., McGrath, J. L., and Rahman, A. (2007) Evidence for actin cytoskeleton-dependent and independent pathways for RelA/p65 nuclear translocation in endothelial cells. J. Biol. Chem. 282, 3940-3950 (Pubitemid 47084484)
48. Huang, J. Y., Shen, B. J., Tsai, W. H., and Lee, S. C. (2004) Functional interaction between nuclear matrix-associated HBXAP and NF-κB. Exp. Cell Res. 298, 133-143
49. Zhang, H. M., Keledjian, K. M., Rao, J. N., Zou, T., Liu, L., Marasa, B. S., Wang, S. R., Ru, L., Strauch, E. D., and Wang, J. Y. (2006) Induced focal adhesion kinase expression suppresses apoptosis by activation NF-κB signaling in intestinal epithelial cells. Am. J. Physiol. Cell Physiol. 290, C1310-C1320
50. Fazal, F., Bijli, K. M., Minhajuddin, M., Rein, T., Finkelstein, J. N., and Rahman, A. (2009) Essential role of cofilin-1 in regulating thrombin-induced RelA/p65 nuclear translocation and intercellular adhesion molecular 1 (ICAM-1) expression in endothelial cells. J. Biol. Chem. 284, 21047-21056
51. Singh, K., Sinha, S., Malonia, S. K., Bist, P., Tergaonkar, V., and Chattopadhyay, S. (2009) Tumor suppressor SMAR1 represses IκBα expression and inhibits p65 transactivation through matrix attachment regions. J. Biol. Chem. 284, 1267-1278
52. Schmid, J. A., Birbach, A., Hofer-Warbinek, R., Pengg, M., Burner, U., Furtmuller, P. G., Binder, B. R., and de Martin, R. (2000) Dynamics of NF-κB and Iκ Bα studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNA by fluorescence resonance energy transfer. J. Biol. Chem. 275, 17035-17042 (Pubitemid 30398945)
53. Qiu, P., and Li, L. (2002) Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression. Circ. Res. 13, 327-332
54. Cha, H. J., Jeong, M. J., and Kleinman, H. K. (2003) Role of thymosin β4 in tumor metastasis and angiogenesis. J. Natl. Cancer Inst. 22, 1674-1680
55. Hsiao, H. L., Wang, W. S., Chen, P. M., and Su, Y. (2006) Overexpression of thymosin beta-4 renders SW480 colon carcinima cells more resistant to apoptosis triggered by FasL and two topoisomerase II inhibitors via downregulating Fas and upregulating Survivin expression, respectively. Carcinogenesis 27, 936-944
56. Oh, S. Y., Song, J. H., Gil, J. E., Kim, J. H., Yeom, Y. I., and Moon, E. Y. (2006) ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance. Exp. Cell Res. 312, 1651-1657
57. Moon, H. S., Even-Ram, S., Kleinman, H. K., and Cha, H. J. (2006) Zyxin is upregulated in nucleus by thymosin β4 in SiHa cells. Exp. Cell Res. 312, 3425-3431 (Pubitemid 44380242)
58. Yarmola, E. G., Somasundaram, T., Boring, T. A., Spector, I., and Bubb, M. R. (2000) Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A. J. Biol. Chem. 275, 28120-28127
59. 4. J. Cell Sci. 117, 5333-5343
60. Legate, K. R., Montanez, E., Kudlacek, O., and Fassler, R. (2006) ILK, PINCH, and parvin: the tiPP of integrin signaling. Nat. Rev. Mol. Cell Biol. 7, 20-31 (Pubitemid 43361569)
61. Kunsch, C., Lang, K. R., Rosen, C. A., and Shannon, M. F. (1994) Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J. Immunol. 153, 153-164
62. Hammond, M. E., Lapointe, G. R., Feucht, F. H., Hilt, S., Gallegos, C. A., Gordon, C. A., Giedlin, M. A., Mullenbach, G., and Tekamp-Olson, P. (1995) IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors. J. Immunol. 155, 1428-1433
63. Marx, J. (2007) Biomedicine. Thymosins: clinical promise after a decades-long search. Science 316, 682-683
64. Sosne, G., Qiu, P., Goldstein, A. L., and Wheater, M. (2010) Biological activities of thymosin β4 defined by active sites in short peptide sequences. FASEB J. 24, 2144-2151
65. Pollard, P. D., and Cooper, J. A. (2009) Actin, a central player in cell shape and movement. Science 326, 1208-1212
66. Olave, I. A., Peck-Peterson, S. L., and Crabtree, G. R. (2002) Nuclear actin and actin-related proteins in chromatin remodeling. Annu. Rev. Biochem. 71, 755-781
67. Miralles, F., and Visa, N. (2006) Actin in transcription and transcription regulation. Curr. Opin. Cell Biol. 18, 261-266
68. Romeo, G. R., Moulton, K. S., and Kazlauskas, A. (2007) Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor-null mouse. Circ. Res. 101, 357-367 (Pubitemid 47267704)
69. Heintz, D., Reichert, A., Mihelic-Rapp, M., Stoeva, S., Voelter, W., and Faulstich, H. (1994) The sulfoxide of thymosin beta 4 almost lacks the polymerization-inhibiting capacity for actin. Eur. J. Biochem. 223, 345-350
70. Rossenu, S., Leyman, S., Dewitte, D., Peelaers, D., Jonckheere, V., Van Troys, M., Vandekerckhove, J., and Ampe, C. (2003) A phage display-based method for determination of relative affinities of mutants: application to the actin-binding motifs in thymosin β4 and the villin headpiece. J. Biol. Chem. 278, 16642-16650 (Pubitemid 36799527)
71. Philp, D., Huff, T., Gho, Y. S., Hannappel, E., and Kleinman, H. K. (2003) The actin binding site on thymosin β4 promotes angiogenesis. FASEB J. 17, 2103-2105
72. Nummela, P., Yin, M., Kielosto, M., Leaner, V., Birrer, M. J., and Holtta, E. (2006) Thymosin β4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase- transfected fibroblasts. Cancer Res. 66, 701-712 (Pubitemid 43165932)
73. Cuschieri, J., Gourlay, D., Garcia, I., Jelacic, S., and Maier, R. V. (2003) Endotoxin-induced endothelial cell proinflammatory phenotypic differentiation requires stress fiber polymerization. Shock 19, 433-439
74. Sun, S. C., Ganchi, P. A., Beraud, C., Ballard, D. W., and Greene, W. C. (1994) Autoregulation of the NF-κB transactivator RelA(p65) by multiple cytoplasmic inhibitors containing ankyrin motif. Proc. Natl. Acad. Sci. U. S. A. 91, 1346-1350
75. Yang, J. P., Hori, M., Sanda, T., and Okamoto, T. (1999) Identification of a novel of nuclear factor-κB, RelA-associated inhibitor. J. Biol. Chem. 274, 15662-15670
76. Higashitsuji, H., Higashitsuji, H., Liu, Y., Masuda, T., Fujita, T., Abdel-Aziz, H. I., Kongkham, S., Dawson, S., John Mayer, R., Itoh, Y., Sakurai, T., Itoh, K., and Fujita, J. (2007) The oncoprotein gankyrin interacts with RelA and suppresses NF-κB activity. Biochem. Biophys. Res. Commun. 363, 879-884 (Pubitemid 47513713)
77. Liu, L., Sakai, T., Tran, N. H., Mukai-Sakai, R., Kaji, R., and Fukui, K. (2009) Nucling interacts with nuclear factor-κB, regulating its cellular distribution. FEBS J. 276, 1459-1470
78. Fan, Y., Gong, Y., Ghosh, P. K., Graham, L. M., and Fox, P. L. (2009) Spatial coordination of actin polymerization and ILK-Akt2 activity during endothelial cell migration. Dev. Cell 16, 661-674
79. Dougherty, G. W., Jose, C., Gimona, M., and Cutler, M. L. (2008) The Rsu-1-PINCH-ILK complex is regulated by Ras activation in tumor cells. Eur. J. Cell Biol. 87, 721-734